Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-343-2 | CAS number: 2050038-81-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 20th September 2019 to 17th April 2020
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: OECD 442E In Vitro Skin Sensitisation Assays addressing the key event on activation of Dendritic cells on the adverse outcome pathway for Skin Sensitistation Adopted: 25 June 2018
- Qualifier:
- according to guideline
- Guideline:
- other: EURL ECVAM DB-ALM Protocol no. 158
- GLP compliance:
- no
- Remarks:
- The study has been conducted with a reputable lab for another international submission.
- Type of study:
- activation of dendritic cells
Test material
- Reference substance name:
- benzyl (3R,4S)-3-{2-[(ethoxycarbonyl)[5-(4-methylbenzenesulfonyl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl}-4-ethylpyrrolidine-1-carboxylate
- EC Number:
- 944-343-2
- Cas Number:
- 2050038-81-6
- Molecular formula:
- C32H35N5O7S
- IUPAC Name:
- benzyl (3R,4S)-3-{2-[(ethoxycarbonyl)[5-(4-methylbenzenesulfonyl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl}-4-ethylpyrrolidine-1-carboxylate
- Test material form:
- solid: particulate/powder
Constituent 1
In vitro test system
- Details on the study design:
- The h-CLAT is an in vitro assay which measures the changes in expression of cell surface markers CD54 (ICAM-1) and CD86 associated with the process of dendritic cell activation in the human acute monocytic leukemia cell line, THP-1. Dendritic cell activation is considered one of the key biological events in the adverse outcome pathway for skin sensitisation, where CD54 and CD86 are subsequently involved in dendritic cell migration to the lymph nodes and T-cell priming. THP-1 cells, seeded at a density of 2.0 x 10 6 cells/ml in culture medium in 24-well plate format, define the Test System. After treatment of the test item or control articles to the test system, the expression of cell surface markers are measured by flow cytometry following cell staining with flourescein isothiocyanate (FITC) labelled antibodies. Cytometry measurement, using propidium iodide (PI) staining, is conducted concurrently to assess whether upregulation of surface expression occurs at subcytotoxic concentrations.
Solubility Determination:
Prior to the preliminary dose range finding assay, the test article was tested in a solubility test to determine an appropriate solvent. The following observations were determined during the test. The test article was found to be soluble at 500 mg/mL in DMSO with approximately 1 minute of vortexing. The test article dilution appeared to be a cloudy, white, non-viscous suspension. The tubes were vortexed immediately prior to dosing and the cloudiness remained.
Dose Range Finding Assay:
A preliminary dose range finding assay was performed to determine the viability of the THP-1 cells after 24 +/- 0.5 hour exposure to 8 test article concentrations. The CV75, which is the calculated test article concentration leading to 75% cell viability was calculated for the test article.
Definitive assays:
Based on the results from the dose range finding assay, the doses were chosen for the test article for the definitive assay. At least 2 valid definitive trials were performed.
The positive control, 2,4-Dinitrochlorobenzene, was tested in the dose rang and definitive trials.
Evaluation of test results:
The relative fluorescence intensity was calculated for the test article and control treated cell population. The EC200 and EC150 values, which are the calculated test article concentrations leading to an RFI of 200 or 150 respectively, were calculated for the test article.
Results and discussion
- Positive control results:
- For the positive control, 2,4-Dinitrochlorobenzene, RFI values of both CD86 and CD54 were predicted to be positive (CD86 RFI ≥150 and CD54, RFI ≥200) and cell viability was >50%.
In vitro / in chemico
Resultsopen allclose all
- Run / experiment:
- other: Dose Range and Definitive Assay
- Parameter:
- other: CV75 µg/mL
- Value:
- 1 000
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- other: µg/mL
- Key result
- Run / experiment:
- other: B1 assay 01 Oct 2019
- Parameter:
- other: CD54 EC200 µg/mL
- Value:
- 370
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- µg/mL
- Key result
- Run / experiment:
- other: B1 assay 01 Oct 2019
- Parameter:
- other: CD86 EC150 µg/mL
- Value:
- 1 000
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- µg/mL
- Key result
- Run / experiment:
- other: B2 assay 08 Oct 2019
- Parameter:
- other: CD54 EC200 µg/mL
- Value:
- 1 000
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- µg/mL
- Key result
- Run / experiment:
- other: B2 assay 8 Oct 2019
- Parameter:
- other: CD86 EC150 µg/mL
- Value:
- 1 000
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- µg/mL
- Key result
- Run / experiment:
- other: B4 assay 15 Oct 2019
- Parameter:
- other: CD54 EC200 µg/mL
- Value:
- 1 000
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- µg/mL
- Key result
- Run / experiment:
- other: B4 assay 15 Oct 2019
- Parameter:
- other: CD86 EC150 µg/mL
- Value:
- 1 000
- Vehicle controls validity:
- not specified
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- µg/mL
- Other effects / acceptance of results:
- Definitive trial 3 did not meet assay acceptance criteria and therefore, was not considered a valid trial
The assay met acceptance criteria when:
The cell viability values of the solvent control was > 90%.
For the solvent control, RFI values of both CD86 and CD54 were less than the positive criteria (CD86 RFI < 150 and CD54 RFI < 200).
For the positive control (DNCB), RFI values of both CD86 and CD54 were predicted to be positive (CD86 RFI >= 150 and CD54 RFI >= 200), and cell viability was > 50%.
For the medium and solvent controls, the MFI ration of both CD86 and CD54 to isotype control was >105%.
The cell viability of the test article-treated cultures was > 50% in at least four doses.
All acceptance criteria for a valid assay were met for the definitive trials.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test article A1634356.0 was considered a non-sensitizer according to h-CLAT.
- Executive summary:
The Human Cell Line Activation Test (h-CLAT) was used to assess the skin sensitisation potential of the test article by monitoring the upregulation of cell surface markers, CD54 and CD86 on the surface of human acute monocytic leukemia cell line, THP-1. The upregulation of CD54 and CD 86 in response to a skin sensitiser is correlated to dendritic cell actication, which is the third key event of the skin sensitisation pathway.
Based on the results from the dose range finding assay, the doses were chosen for the test article for the definitive assay. At least 2 valid definitive trials were performed.
The positive control, 2,4-Dinitrochlorobenzene, was tested in the dose rang and definitive trials.The relative fluorescence intensity was calculated for the test article and control treated cell population. The EC200 and EC150 values, which are the calculated test article concentrations leading to an RFI of 200 or 150 respectively, were calculated for the test article.
As the test article elicted an EC200 >1000 for CD54 and an EC150 >1000 for CD86, with cell viability ≥50% in at least two independent runs, A-1634356.0 is considered a non-sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.